A polymerase chain reaction (PCR) method was developed that was capable of detecting a wide range of medically important fungi from clinical specimens. The primer pair was designed in conserved sequences of 1 8s-ribosomal RNA genes shared by most fungi. The lower limit of detection of this PCR technique was 1 pg of Cundidu ulbicans genomic DNA by ethidium bromide staining and 100 fg after Southern analysis. A 687-bp product was amplified successfully by PCR from all 78 strains of 25 medically important fungal species studied, including Candida spp., Hansenula spp., Saccharomyces cereuisiae, Cryptococcus neoformans, Trichosporon beigelii, Malassezia furfur, Pneumocystis curinii, Aspergillus spp., and Penicillium spp., but not from any strains of Mucor spp., Escherichia coli, or methicillinresistant Staphylococcus aureus (MRSA), calf thymus or human placenta. This specificity was subsequently confirmed by Southern analysis. PCR analysis of blood specimens collected from mice systemically infected with C. albicans and clinical samples including blood, cerebrospinal fluid and sputum appeared to be a more sensitive diagnostic method for invasive fungal infections than a conventional blood culture technique.
Introduction
Invasive candidosis, aspergillosis and other lifethreatening fungal infections occur increasingly frequently in immunocompromised patients. Furthermore, the variety of causative agents is expanding.lP3 These factors make laboratory diagnosis by conventional culture methods more difficult and time-consuming. Serodiagnostic kits have been developed for early diagnosis, but some of these have problems in sensitivity or specificity, or both, even though they are rapid to p e r f~r m .~-~ To improve the sensitivity and specificity of detection of pathogenic fungi, molecular biological methods have been developed recently. Some laboratory diagnostic methods with Southern hybridisation have been reported. Gabal' detected A . .fumigatus DNA in an amount equivalent to 3 cfu with a total Aspergillus fumiyatus chromosomal DNA probe'. Holmes et al.' reported that Candida albicans specific repetitive sequence was detectable from human blood specimens that contained 2 500 yeast cells/ml. DNA probes for ribosomal RNA (rRNA) of several species of pathogenic fungi are now available commer~ially.~
The polymerase chain reaction (PCRlO) is the most sensitive and specific technique of detecting a specific ~~ Received 30 Sept. 1993; revised version accepted 16 Nov. 1993.
DNA sequence, and species-specific PCR-diagnostic methods applicable to C. albicans, A . fumigatus or Pneumocystis carinii are These PCR techniques are capable of detecting > 1 pg of fungal genomic DNA or one-to-15 fungal cells with great accuracy. The increasing incidence of invasive fungal infections caused by uncommon fungi including nonalbicans Candida spp., Hansenula spp., Saccharomyces cerevisiae, Trichosporon beigelii, Malassezia furfur and Penicillium spp., in imrnunocompromised hosts1 3 7 21, 22 has made it essential to have a means of identifying a broad variety of medically important fungi. Hopfer et ~1 . '~ reported a PCR method with a previously described primer to meet this need and attempted to differentiate species with restriction analysis of amplified products. However, as the primer system they used was developed originally for the study of fungal phylogenetics, it is questionable whether the system is also applicable to medically important fungi. In the present study a new PCR primer system was used that had broad detection capability with a primer pair based on conserved DNA sequences of 18s-rRNA genes of medically important fungi in the GenBank data base. This system was applied to blood specimens from a murine model of invasive candidosis and to clinical specimens from human patients. 
Materials and methods

Organisms
The following strains were used in this study: C. 
DNA preparation from fungal cells
All fungal strains were grown in or on YMPG broth or agar (yeast extract 0.3% w/v, malt extract 0.3% w/v, peptone 0.5 YO w/v, glucose 1 YO, with or without agar 1.5 YO w/v) at 27" or 37°C for 1-2 days.
Small scale extraction of genomic DNA from yeastlike fungi was performed as described by Philippsen et For rapid extraction of DNA from yeast-like fungi, a small amount of the yeast colony was suspended in 100 pl of lysis buffer (100 mM Tris-HC1, pH 7.5, SDS 0.5 % w/v, 30 mM EDTA). After vortex mixing for 5 s, this mixture was incubated at 100°C for 15 min; 100 pl of 2.5 M potassium acetate was added and it was mixed again, incubated on ice for 60 min, centrifuged at 12000 rpm for 5 min and the supernate was transferred to a new tube. DNA was precipitated with an equal volume of isopropanol, washed with 0-5 ml of ethanol 99%, dried and resuspended in 100 pl of distilled water. The PCR template was 2pl of this DNA solution.
Small scale> extraction of DNA from filamentous fungi was performed as described by Bainbridge et and rapid extraction as described by Cenis." E. coli genomic DNA was extracted as described by a1. 25 
Sambrook et aLZ8
Oligonucleotide design
The design of oligonucleotides used in this study was based on comparison of the sequences of 18s (1 6s-like) ribosomal RNA genes (rDNA) in the GenBank data base (accession nos: M60302, C. racernosus, E. coli or H. sapiens were analysed with the PC/GENE (Intelligenetics Inc., Genofit. SA, USA, kindly loaned by Teijin Co., Ltd, Yokohama, Japan) and two oligonucleotide primers-B2F : 5'-ACT-TTCGATCGTAGGATAG-3' and B4R : 5'-TGATC-GTCTTCGATCCCCTA-3'-made by Genosis Biotechnologies Tnc., Texas, USA, The primers were expected to amplify a fragment of 687 bp within the 18s-rDNA. Also, one oligonucleotide probe 18SIN3 : Fig. 1 . Specificity of the PCR with primer pair B2F and B4R. Agarose 1.2 % gel electrophoresis of PCR products amplified from 10 ng of genomic DNA templates from various organisms was done. A, stained by ethidium bromide and visualised by UV irradiation; B, followed by the chemiluminescence method of Southern analysis detected by Polaroid 612, I S 0 20000 film. Lanes: M, HindIII-digested lambda DNA; 1, A . fumigatus TIMM3150; 2, A.Javus TIMM0057; 3, A . niyer TIMM0113; 4, P . commune TIMM1331; 5, C. albicans TIMM1768; 6, C. parapsilosis TIMM0292; 7, C. tropicalis TIMM0313; 8, Cr. neoformans TIMM0354; 9, Muc. circinelloides TIMM1324; 10, E. coli; 11, human.
5'-CTGAGAAACGGCTACCACAT-3'. an internal region within the amplified products, "as made for Southern hybridisation.
PCR
Each PCR assay contained 10 pl of 10 x reaction buffer [600 mM Tris-HC1, pH 8.5, 150 mM (NH,),SO,, 15 m M MgCl,], 100 p~ each of dATP, dCTP, dGTP and dTTP (Pharmacia, Uppsala, Sweden), 2.5 U of Taq polymerase (Pharmacia), 30 pmol of each primer and DNA template solution. The volume was made up to 100 pl with distilled water. Each mixture was heated to 94°C for 5 min and PCR was performed under the following conditions: 94°C for 1 min; 55°C for 2 min and 72°C for 3 min; 30 cycles. Thermal cycles were terminated by polymerisation at 72°C for 10 min.
To examine the specificity of this system, the samples of genomic DNA extracted from the organisms were tested to see whether the primer pair amplified the Infection of mice with C. albicans same length of DNA products; 10 ng of template DNA was used per reaction and Southern blot analysis was done for confirmation of the results.
To determine the lower limit of detection by PCR with the primer pair B2F and B4R, assays were performed with the genomic DNA of C. albicans TIMM2726 serially diluted to give a concentration range of 100 fg-10 ng. Fungal DNA solutions, which were extracted as described by Buchman et al.ll from 100 pl of normal human blood containing EDTA plus 10, lo1, lo2, lo3 or lo4 cells of C. albicans TIMM1768, were also tested by PCR and Southern blot analysis.
On day 0, eight of 10 female ICR mice (5 weeks old; obtained from Nippon Bio-Supp. Center, Tokyo, Japan) were given lo6 cells of C. albicans TIMM1768 by intravenous injection in 200 pl of sterile saline. Two mice were killed 1-4 days after inoculation, dissected and blood samples were taken from the hearts, to which 5 pl of 0.5 M EDTA was added. From each blood sample, 5Opl was cultured on YMPG agar incubated at 37°C for 2 days. Remaining blood samples were stored immediately at -80°C until needed. DNA was extracted from 100 pl of the blood sample from each mouse as described by Buchman et al.ll Clinical specimens Blood, cerebrospinal fluid or sputum was taken from immunocompromised patients with fever who did not respond to any antibacterial chemotherapy and 100-pl volumes of the samples were stored at -80°C until needed. DNA extraction was performed as described by Buchman et al.ll
Serodiagnostic tests
Cand-Tec4 (Ramco, Houston) ; Pastorex Aspergillus5 (Diagnostics Pastorex, Paris) ; Serodirect Eiken Cryptococcus5 (Eiken Kagaku Corp., 1-33-8 Hongo, Bunkyo-ku, Tokyo 1 13 Japan) and G test6 (Seikagaku Corp., 2-1-5 Hashimoto-cho, Nihonbashi, Chuo-ku, Tokyo 103 Japan) were used as shown in table 111.
Agarose gel electrophoresis and Southern analysis
PCR product (5-10 pl) was electrophoresed in agarose 1.2% gel and visualised by staining with ethidium bromide. The DNA was transferred from the gels on to nylon membranes (Hybond N + ; Amersham), and then hybridised with the 18SIN3 probe labelled with a chemiluminescence detection system (ECL 3'-oligolabelling and detection system ; Amersham). The membranes were washed according to the manufacturer's instructions and exposed to I S 0 20 000 instant film (Polaroid 612 film; Polaroid, Cambridge, USA) for 1 s-30min in the camera luminometer system (Camlight 50 1 ; Analytical Luminescence Laboratory, San Diego, CA, USA).
Results
Specificity of detection of fungi by PCR
A product of c. 700 bp was amplified by PCR from all 78 strains of 25 medically important fungal species tested (table I), but not from Muc. circinelloides, Muc. racemosus, E. coli, MRSA, calf thymus or human placenta. No amplification was observed without templates. Fig. 1A shows PCR products amplified from eight different fungi, but not from Muc. circinel- loides, E. coli or man. No differences in length were found among any of the species. This specificity was subsequently confirmed by Southern analysis ( fig. 1 B) .
Sensitivity of detection of C. albicans by PCR
PCR with the primer pair B2F and B4R was able to detect 1 pg of C. albicans genomic DNA with ethidium bromide staining ( fig. 2A) and 100 fg by chemiluminescence (fig. 2B ). This sensitivity is equivalent to the detection of one-to-two yeast cells.24 PCR with the template extracted from blood samples containing C. albicans cells detected lo2 C. albicans cells by ethidium bromide staining and 10 cells by Southern analysis (data not shown). There was no amplified product from blood without C. albicans cells and there was no cross-hybridisation to the probe 18SIN3.
Detection of fungal-speciJic DNA in blood specimens from mice infected with C. albicans A summary of the PCR and culture results and the presence of kidney abscesses is given in table 11. Only one sample on day two after infection (mouse no. 3) showed a positive culture. The culture-positive sample was also positive by PCR, and five of seven culturenegative samples also resulted in a positive PCR result. In every mouse from day two to day four, multiple foci of kidney abscesses were observed. Since the intensities of PCR products from culture-negative samples were as strong as those from culture-positive samples and the results of PCR, culture and detection of kidney abscesses were all negative in uninfected mice, this does not appear to be an indication of false positive results. All PCR products led to amplification of single fragments c. 700 bp in length, and they were confirmed as target DNA by Southern analysis.
Detection of fungal-speciJic DNA from clinical specimens
A summary of the results of PCR, culture and diagnostic kits is given in table 111. The samples from patients 1, 2 and 3 were culture-positive: C. albicans from blood; H. anomala from cerebrospinal fluid and A. fumigatus from sputum, respectively; all of them gave positive results in the PCR. Samples from patients no. 4 were PCR positive; the blood culture was negative, but CSF was culture positive for Cr. neoformans. Blood samples from patients 5, 6 and 7 (immunocompromised hosts who were resistant to anti-bacterial antibiotics) gave negative results in culture, but two of the three were positive in the PCR. Each amplified DNA fragment revealed a single band of c. 700 bp and these bands were confirmed as target DNA by Southern analysis.
Discussion
The results of this study demonstrated firstly that the 18s-rDNA-based PCR method had high sensitivity and specificity for a wide range of medically important fungi. Secondly, the capability of this technique to identify these fungi from the blood of an animal model and clinical specimens of blood, cerebrospinal fluid and sputum make it useful for clinical diagnosis. The sensitivity of this PCR system with the primer pair B2F and B4R, with both purified DNA and yeast cells contained in blood reached a detection level as high as that of the previously reported PCR method for pathogenic fungi,"-15* 23 when purified DNA or cultured cells of C. albicans were used as the templates.
There are only three report^^^,'^^'^ referring to the sensitivity of PCR with artificial samples containing body fluids and the lower limit was the same as that reported here : 10-100 cells or cfu prepared from blood or urine. Moreover, from the results of the animal model and clinical specimens, PCR was shown to be more sensitive than culture methods with 0.1 ml of blood samples. This may be explained by the loss of viability of fungi contained in blood, but > lo2 cells are estimated to exist in 0.1 ml of blood if calculated as DNA. In this sensitivity study, two kinds of PCR templates were used, the purified DNA solution and crude DNA extracts from blood containing C. albicans cells. Assuming that one C. albicans cell contains c. 37 fg of DNA,29 Buchman's method of fungal DNA preparation from clinical samples including blood may be highly efficient.
DNA sequences of 18s-rDNA of various organisms have been deposited in the GenBank data base for purposes of phylogenetic 30* 31 Our primer pair, B2F and B4R, was designed in conserved sequences of 18S-rDNA to be specific only for medically important fungi and this specificity was achieved. For example, there have been numerous reported cases of systemic infection with M . furfur22 and this was detected successfully by the PCR system although the organism cannot be detected by a conventional culture system. Pn. carinii (which was recently demonstrated to be a fungus)32 was also detected by this PCR system. Some reports of detection of Pn. carinii with PCR have been published.16-20 Lipschik et aZ.l6 reported the PCR diagnosis of Pn. carinii infection based on 18S-rDNA different from that used here. Their primer pair was designed to have species-specificity as reported by many 0thers.~'-~~9*'* 2o D iagnostic kits also reveal less sensitivity on tested samples than by our technique. New technology, such as enzymic detection of PCR and the non-radioisotopic method of Southern analysis as demonstrated in this study, make PCR applicable to the routine laboratory diagnosis of infections by medically important fungi. Further evaluation of this PCR method with other clinical specimens is underway.
